Publications by authors named "Hamza Zughaier"
Article Synopsis
- - Triple-negative breast cancer (TNBC) is a major health issue globally, and while chemotherapy was the primary treatment, immunotherapy is showing potential, especially in patients with mismatch repair protein (MMRP) deficiency.
- - A study analyzing TNBC patients from 2015 to 2021 found that 9.2% exhibited deficient MMR, with most showing loss of specific proteins like PMS2 and MLH1.
- - Although patients with dMMR showed higher five-year survival rates, the overall survival difference compared to proficient MMR patients wasn't significant; dMMR status may help predict outcomes and target immunotherapy treatments.
